Focus Partners Advisor Solutions LLC Has $584,000 Holdings in HCA Healthcare, Inc. $HCA

Focus Partners Advisor Solutions LLC grew its position in HCA Healthcare, Inc. (NYSE:HCA) by 8.2% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,525 shares of the company’s stock after purchasing an additional 116 shares during the quarter. Focus Partners Advisor Solutions LLC’s holdings in HCA Healthcare were worth $584,000 as of its most recent SEC filing.

A number of other institutional investors also recently modified their holdings of HCA. Nuveen LLC bought a new position in shares of HCA Healthcare in the first quarter valued at approximately $569,217,000. Pacer Advisors Inc. raised its position in shares of HCA Healthcare by 6,237.9% in the first quarter. Pacer Advisors Inc. now owns 1,350,933 shares of the company’s stock valued at $466,815,000 after purchasing an additional 1,329,618 shares during the period. Price T Rowe Associates Inc. MD raised its position in shares of HCA Healthcare by 83.4% in the first quarter. Price T Rowe Associates Inc. MD now owns 2,399,372 shares of the company’s stock valued at $829,104,000 after purchasing an additional 1,091,416 shares during the period. Goldman Sachs Group Inc. increased its position in HCA Healthcare by 49.1% during the first quarter. Goldman Sachs Group Inc. now owns 1,781,459 shares of the company’s stock worth $615,583,000 after acquiring an additional 587,036 shares during the period. Finally, Abdiel Capital Advisors LP bought a new position in HCA Healthcare during the first quarter worth $164,835,000. Institutional investors own 62.73% of the company’s stock.

Analyst Ratings Changes

Several equities research analysts have issued reports on the stock. Wall Street Zen raised shares of HCA Healthcare from a “buy” rating to a “strong-buy” rating in a report on Saturday, October 25th. Bank of America upped their price target on shares of HCA Healthcare from $430.00 to $470.00 and gave the stock a “neutral” rating in a research report on Monday. Cowen reissued a “buy” rating on shares of HCA Healthcare in a report on Monday. Wells Fargo & Company increased their target price on HCA Healthcare from $375.00 to $412.00 and gave the stock an “equal weight” rating in a research note on Tuesday, October 7th. Finally, KeyCorp increased their target price on HCA Healthcare from $465.00 to $475.00 and gave the stock an “overweight” rating in a research note on Monday. Fourteen equities research analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $473.53.

Insiders Place Their Bets

In other HCA Healthcare news, EVP Michael S. Cuffe sold 3,836 shares of the stock in a transaction on Monday, September 8th. The stock was sold at an average price of $418.84, for a total transaction of $1,606,670.24. Following the transaction, the executive vice president owned 31,503 shares in the company, valued at $13,194,716.52. This trade represents a 10.85% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 1.30% of the stock is owned by insiders.

HCA Healthcare Price Performance

Shares of HCA Healthcare stock opened at $468.21 on Thursday. The business has a fifty day simple moving average of $418.76 and a two-hundred day simple moving average of $385.09. HCA Healthcare, Inc. has a 1 year low of $289.98 and a 1 year high of $475.38. The company has a market capitalization of $109.56 billion, a price-to-earnings ratio of 18.10, a P/E/G ratio of 1.37 and a beta of 1.40.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings results on Friday, October 24th. The company reported $6.96 earnings per share (EPS) for the quarter, beating the consensus estimate of $5.64 by $1.32. The business had revenue of $19.16 billion during the quarter, compared to the consensus estimate of $18.55 billion. HCA Healthcare had a negative return on equity of 792.25% and a net margin of 8.53%.The company’s quarterly revenue was up 9.6% on a year-over-year basis. During the same quarter last year, the firm posted $4.90 EPS. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. As a group, equities analysts anticipate that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Monday, December 29th. Shareholders of record on Monday, December 15th will be given a dividend of $0.72 per share. The ex-dividend date is Monday, December 15th. This represents a $2.88 annualized dividend and a yield of 0.6%. HCA Healthcare’s dividend payout ratio (DPR) is presently 11.13%.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.